Home/Inomagen Therapeutics/Eric Sandberg

ES

Eric Sandberg

Chief Business Officer

Inomagen Therapeutics

Therapeutic Areas

Cardiovascular Atrial Fibrillation

Inomagen Therapeutics Pipeline

Drug	Indication	Phase
Non-viral gene therapy for Atrial Fibrillation	Atrial Fibrillation	Pre-clinical

Leadership Team at Inomagen Therapeutics

Rishi Arora, MD

Gerard Abate, MD

Chief Medical Officer

Robert Moen, MD, Ph.D.

VP, Research & Development

View full Inomagen Therapeutics profile